Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

Auerbach JM, Segal M. (1996). Muscarinic receptors mediating depression and long–
term potentiation in rat hippocampus. J. Physiol, 492: 479–493.
Avoli M, Louvel J, Pumain R, Köhling R. (2005). Cellular and molecular mechanisms
of epilepsy in the human brain. Prog Neurobiol, 97: 166–200.
Axmacher N, Stemmler M, Engel D, Draguhn A, Ritz R. (2004). Transmitter
metabolism as a mechanism of synaptic plasticity: a modeling study. J
Neurophysiol, 91: 25–39.
Baba H, Kohno T, Okamoto M, Goldstein PA, Shimoji K, Yoshimura M. (1998).
Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal
dorsal horn. The Journal of Physiology, 508: 83–93.
Babb TL, Brown WJ. (1987). Pathological findings in epilepsy. In: Engel JJr (ed)
Surgical treatment of the epilepsies. Raven Press, New York, P: 511–540.
Babb TL, Pretorius JK, Kupfer WR, Crandall PH. (1989). Glutamate decarboxylase–
immunoreactive neurons are preserved in human epileptic hippocampus. J
Neurosci, 9: 2562–2574.
Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F,
Richter–Olesen H, De Camilli P. (1990). Identification of the 64K autoantigen in
insulin–dependent diabetes as the GABA–synthesizing enzyme glutamic acid
decarboxylase. Nature, 347: 151–156.
Bak LK, Schousboe A, Waagepetersen HS. (2006). The glutamate/GABA–glutamine
cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J
Neurochem, 98: 641–653.